Literature DB >> 7997851

T cells from children with IDDM are sensitized to bovine serum albumin.

R Cheung1, J Karjalainen, J Vandermeulen, D P Singal, H M Dosch.   

Abstract

Epidemiological and experimental evidence suggested that denial of dietary cow milk protein early in life protects genetically susceptible children and animals from insulin-dependent diabetes (IDDM). Bovine serum albumin (BSA) was proposed as a candidate milk-borne mimicry antigen responsible for the diabetogenic cow milk effect. Elevated anti-BSA antibodies have been observed in patients and diabetic rodents, and these antibodies precipitate p69 from islet cell lysates. IDDM is a T cell mediated disorder but efforts to detect BSA-specific T cells in diabetic children have so far failed. We describe here a culture system which allowed the detection of BSA-specific T cells and we mapped this response to the ABBOS peptide (pre-BSA position 152-169) previously identified as a possible mimicry epitope. ABBOS-sensitized T cells were found in 28/31 children with recent onset IDDM but not in non-diabetic controls nor in children with SLE or JRA. T cell proliferative responses declined within the first few years of diabetes diagnosis. Although no effector cell role for BSA/ABBOS specific T lymphocytes has been demonstrated, the presence of BSA peptide-specific T cells strengthens the postulated link between a cow milk protein and IDDM.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7997851     DOI: 10.1111/j.1365-3083.1994.tb03514.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  2 in total

1.  ICA69 is expressed equally in the human endocrine and exocrine pancreas.

Authors:  M I Mally; V Cirulli; A Hayek; T Otonkoski
Journal:  Diabetologia       Date:  1996-04       Impact factor: 10.122

2.  Molecular Mimicry between SARS-CoV-2 and Human Endocrinocytes: A Prerequisite of Post-COVID-19 Endocrine Autoimmunity?

Authors:  Leonid P Churilov; Muslimbek G Normatov; Vladimir J Utekhin
Journal:  Pathophysiology       Date:  2022-08-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.